BIOCRYST PHARMACEUTICALS, INC. Common Stock, Capital Shares Reserved for Future Issuance
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Common Stock, Capital Shares Reserved for Future Issuance of 70.57 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-05
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 70.57M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 64.83M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 68.50M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 71.17M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 70.57M shares 10-Q · filed 2026-08-05 | |
| 2026-03-31 | 64.83M shares 10-Q · filed 2026-05-06 | |
| 2025-12-31 | 68.50M shares 10-Q · filed 2026-08-05 | |
| 2025-09-30 | 71.17M shares 10-Q · filed 2025-11-04 | |
| 2025-06-30 | 71.79M shares 10-Q · filed 2025-08-05 | |
| 2025-03-31 | 61.49M shares 10-Q · filed 2025-05-06 | |
| 2024-12-31 | 62.16M shares 10-K · filed 2026-02-26 | |
| 2024-09-30 | 63.67M shares 10-Q · filed 2024-11-05 | |
| 2024-06-30 | 64.16M shares 10-Q · filed 2024-08-06 | |
| 2024-03-31 | 57.44M shares 10-Q · filed 2024-05-07 | |
| 2023-12-31 | 58.02M shares 10-K · filed 2025-02-25 | |
| 2023-09-30 | 72.36M shares 10-Q · filed 2023-11-08 | |
| 2022-12-31 | 67.23M shares 10-K · filed 2024-02-27 | 67.24M shares 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |